BRIEF published on 09/23/2024 at 08:20, 1 year 6 months ago Tissue Regenix Group Achieves First Pre-Tax Profit Market Expansion Pre-tax Profit Tissue Regenix Soft Tissue Repair Bone Repair
PRESS RELEASE published on 09/23/2024 at 08:15, 1 year 6 months ago Hardman & Co Research on Tissue Regenix (TRX): Maiden pre-tax profit Hardman & Co Research reports on Tissue Regenix (TRX) achieving maiden pre-tax profit. TRX focuses on soft tissue and bone repair technologies, showing strong growth and profitability Hardman & Co Research Pre-tax Profit Tissue Regenix Soft Tissue Repair Bone Repair
BRIEF published on 06/25/2024 at 10:48, 1 year 9 months ago Decline of UK Life Sciences Sector Raises Concerns Investment Tissue Regenix Institutional Support UK Life Sciences Healthcare Index
PRESS RELEASE published on 06/25/2024 at 10:43, 1 year 9 months ago Hardman & Co Insight: Survival of the UK life sciences sector Hardman & Co Research presents insights on the survival of the UK life sciences sector, highlighting challenges and opportunities for institutional investors. Discover more in the full report Investment Opportunities Hardman & Co Research Institutional Investors UK Life Sciences Sector Healthcare Stocks
BRIEF published on 04/10/2024 at 08:20, 1 year 11 months ago Hardman & Co Research Highlights Tissue Regenix's Impressive Growth Streak EBITDA Growth Tissue Regenix DCELL® BioRinse®
PRESS RELEASE published on 04/10/2024 at 08:15, 1 year 11 months ago Hardman & Co Research on Tissue Regenix (TRX): Six consecutive periods of >20% growth Hardman & Co Research highlights Tissue Regenix (TRX) with six consecutive periods of >20% growth, backed by strong commercial partners and expansion plans Hardman & Co Research Growth Investments Tissue Regenix EBITDA-positive
PRESS RELEASE published on 09/18/2023 at 11:40, 2 years 6 months ago Hardman & Co Research on Tissue Regenix (TRX): Continuing postive momentum 1H'23
PRESS RELEASE published on 04/05/2023 at 15:55, 2 years 11 months ago Hardman & Co Research on Tissue Regenix (TRX): Turning profitable and cash-generative
Published on 03/26/2026 at 11:07, 26 minutes ago U.S. Mined and Refined Metals as well as Rare Earth Elements to Be Tokenized in Historic American Strategic Minerals and Datavault AI Deal
Published on 03/26/2026 at 11:00, 33 minutes ago Stagwell Expands the Harris Poll's Harrisquest Across Europe
Published on 03/26/2026 at 08:05, 3 hours 28 minutes ago Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 6 hours 38 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 11:03, 30 minutes ago EQS-Adhoc: VIDINEXT AG: Marketing agreement with Telekom Deutschland GmbH
Published on 03/26/2026 at 11:00, 33 minutes ago Genel Energy PLC: Posting of Annual Report and Notice of AGM
Published on 03/26/2026 at 11:00, 33 minutes ago Genel Energy PLC: Report on payments to governments for the year 2025
Published on 03/26/2026 at 11:00, 33 minutes ago ABB Ltd: ABB share buybacks - March 19, 2026 - March 25, 2026
Published on 03/26/2026 at 11:00, 33 minutes ago Independent study reveals 44% ROI with EQS Compliance Cockpit and payback in under six months
Published on 03/26/2026 at 07:30, 4 hours 3 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 17 hours 2 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 17 hours 48 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
